June 30, 2003 |
Over the last two years, doctors have diagnosed Andrea Robinson with half a dozen severe mental disorders and prescribed her a series of strong medications, including antidepressants and an antipsychotic. Her parents are beside themselves. Andrea is 5 years old. "It's a very difficult situation," Tammy Robinson of Ottawa said about her daughter, who appears to suffer the telltale mood swings of bipolar disorder and is now responding well to a mood-stabilizing drug.
October 21, 2012 |
One in five Americans over age 18 suffers from a diagnosable mental illness in any given year. That's upward of 40 million potential voters. So why have we heard virtually nothing about mental health care from either candidate during this campaign? Just to provide a little context, according to the American Cancer Society's latest numbers, about 12 million Americans are living with some form of cancer; 400,000 Americans suffer from multiple sclerosis; 1 million from Parkinson's and 1.2 million are living with HIV/AIDS.
May 23, 2013 |
Catherine Zeta-Jones has returned home after leaving a treatment facility where she was being treated for her bipolar II disorder. The actress was spotted driving to her New York City apartment Tuesday after dropping off her daughter at school, according to People and E! News . Zeta-Jones, 43, checked herself into the facility on April 29 and was set to be there for 30 days. She was there to undergo some healthy "maintenance," according to TMZ. Her rep did not immediately return a request for comment.
December 14, 2008 |
'I need these pills refilled," the weary mother says, displaying an array of empty bottles on the desk in my office. "My son is bipolar." The boy, a quiet slip of a 10-year-old, had been prescribed two antipsychotics, two mood stabilizers, one antidepressant, two attention deficit disorder medications and another medication to manage the side effects of the antipsychotics. The mother explained that she had just regained custody of her son and his brother.
March 11, 2011 |
Pharmaceutical giant AstraZeneca will pay $68.5 million as part of a multistate settlement over allegations that it promoted its psychiatric drug Seroquel for unapproved uses, such as treating insomnia and Alzheimer's disease. The settlement will be shared by 37 states and the District of Columbia, California Atty. Gen. Kamala D. Harris said Thursday. California will receive more than $5.2 million, which will be used to cover litigation costs and add to the state's consumer protection fund, Harris said.
CALIFORNIA | LOCAL
May 11, 2002 |
The Church of Scientology handed over $8.6 million this week to resolve the lawsuit of a former member who charged that the controversial church caused him to develop bipolar disorder and nearly drove him to suicide. The payment came nearly 22 years after Lawrence Wollersheim, 53, filed his 1980 lawsuit, and nearly 16 years after a California jury awarded him $30 million. In the intervening years, the award was reduced on appeal to $2.5 million and went all the way to the U.S.
February 2, 2003 |
John Matuszak vowed to keep his Oakland Raider teammates in line. Instead, he kept them out all night. That was during the 1981 Super Bowl week in New Orleans, when Matuszak's capacity for alcohol and Quaaludes was as enormous as his 6-foot-8, 280-pound body. He basically drank Bourbon Street dry, the Raiders wound up beating Philadelphia for their second Super Bowl title, and fans to this day delight in recounting stories of the wild-eyed defensive lineman they called Tooz.
July 21, 2003 |
Bipolar disorder, in which a person's mood cycles between two extremes -- depression and mania -- is usually treated with a mood stabilizer and, when needed, an antidepressant. But researchers at the UCLA Neuropsychiatric Institute have found that the standard use of these drugs often leads to a relapse. According to established guidelines, the antidepressant should be discontinued within three to six months after a person recovers from an acute episode of depression.
April 13, 2009 |
About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome mood swings. Mostly, they were depressed or anxious, and frustrated by the pace of their recovery. Leuchter wondered what was up: Depressed patients didn't usually seek out drugs used to quell psychiatry's most disturbing symptoms.